Skip to content

Encore Capital Group ECPG Impairment of long-lived assets

Impairment of long-lived assets at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$0
UBS
United BanksharesUBSI
$13.75K-74.9%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$0-100%
Encore Capital Group logo
Encore Capital GroupECPG
$0-100%
WaFd, Inc. logo
WaFd, Inc.WAFD
$0-100%
Adaptive Biotechnologies logo
Adaptive BiotechnologiesADPT
$347K

Other financials

Income statement

See full
Revenue$475.4M+21.0%
Operating income$184.0M+42.3%
Net income$86.2M+84.3%
EPS (diluted)$3.86+100%

Balance sheet

See full
Cash & equivalents$227.2M+21.4%
Total debt$4.0B+6.4%
Total equity$1.0B+26.3%
Total assets$5.5B+9.7%

Cash flow

See full
Operating cash flow$82.3M+81.8%
CapEx$4.9M-30.5%
Free cash flow$77.5M+102%

Valuation

See full
Market cap$1.84B+84.9%
Enterprise value$5.65B+20.2%
P/E6.2×
P/S+0.3×

Profitability

See full
Operating margin36.8%
Net margin16%+11.9pp
FCF margin9%+0.2pp

Returns & leverage

See full
Return on equity32%+24.8pp
Debt / equity3.9×-0.7×

Where this comes from

Reported directly by Encore Capital Group in its filing.

Tagged under the XBRL concept us-gaap:TangibleAssetImpairmentCharges.

The official record: Encore Capital Group’s 10-K, filed February 25, 2026, on SEC EDGAR. View the filing →

Ask your AI about Encore Capital Group's impairment of long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Encore Capital Group's impairment of long-lived assets?
Encore Capital Group (ECPG) reported impairment of long-lived assets of $0 in Q4 2025.
How has Encore Capital Group's impairment of long-lived assets changed year-over-year?
Encore Capital Group's impairment of long-lived assets decreased by 100.0% year-over-year, from $4.64M to $0.
What is the long-term trend for Encore Capital Group's impairment of long-lived assets?
Over 3 years (2022 to 2025), Encore Capital Group's impairment of long-lived assets has grown at a -100.0% compound annual growth rate (CAGR), from $4.08M to $0.
What does impairment of long-lived assets mean?
Represents non-cash charges recognized when the carrying amount of long-lived assets exceeds their fair value. This metric indicates a reduction in the expected future economic benefit of tangible assets, often signaling operational challenges or asset devaluation. Investors monitor this to assess the quality of the asset base and the accuracy of historical capital expenditure valuations.